This dual MDR1 and BCL2 siRNA-loaded PLGA nanoparticle system was a viable strategy to overcome the chemoresistance on ovarian cancer cells (paclitaxel-resistant cell line SKOV3-TR and cisplatin-resistant cell line A2780-CP20) by enhancing cellular drug sensitivity[85]. The gene discussed is ABCB1; the disease is ovarian cancer.